Sample | Title | Value | Rank |
GSM52504 | SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 1) | 102.3 | 68 |
GSM52508 | SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 2) | 121.4 | 71 |
GSM52518 | SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 1) | 115.6 | 70 |
GSM52519 | SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 2) | 68.6 | 62 |
GSM52516 | SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2 plus doxorubicin (sample 1) | 92.8 | 67 |
GSM52517 | SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2 plus doxorubicin (sample 2) | 84.6 | 65 |